Bubonic plague

Bubonic plague
Photo Credit: Content Providers(s): CDC · Public domain · source
Name	Bubonic plague
Field	Infectious disease, Epidemiology
Symptoms	Fever, chills, swollen lymph nodes, Sepsis, shock
Complications	Pneumonia, Meningitis, Septic shock
Onset	2–6 days
Causes	Yersinia pestis
Risks	Flea exposure, rodent contact, travel to endemic regions
Diagnosis	Culture, Polymerase chain reaction, serology
Prevention	Vector control, Antibiotic prophylaxis, Vaccination
Medication	Streptomycin, Doxycycline, Ciprofloxacin
Frequency	Endemic foci in Africa, Asia, Americas

Bubonic plague is an acute infectious disease caused by the bacterium Yersinia pestis that primarily affects lymphatic tissue and is transmitted by infected fleas and contact with infected rodents. Historically associated with catastrophic pandemics, the illness remains a zoonosis with sporadic human cases in parts of Democratic Republic of the Congo, Madagascar, Peru, Kazakhstan, and United States. Modern clinical care, laboratory diagnostics, and public health measures reduce mortality compared with pre-antibiotic eras, though outbreaks can challenge public health systems such as World Health Organization and national agencies like the Centers for Disease Control and Prevention.

History

The disease was central to the Justinianic Plague of the 6th century, the Black Death of the 14th century, and recurrent epidemics during the 17th–19th centuries that reshaped populations in Byzantine Empire, Mongol Empire, Kingdom of France, Kingdom of England, Holy Roman Empire, and Ottoman Empire. Notable episodes include the 1347–1351 pandemic that devastated Florence, Venice, London, and Paris and influenced contemporaries such as Giovanni Boccaccio and Ibn Battuta. Later outbreaks affected colonial networks centered on Lisbon, Amsterdam, Seville, and Marseille, provoking responses by municipal authorities in Venice with quarantine institutions like the Lazaretto and measures recorded by figures including Girolamo Fracastoro. Scientific breakthroughs involved investigators such as Alexandre Yersin, Kitasato Shibasaburō, Paul-Louis Simond, and later laboratory contributions from Louis Pasteur and Robert Koch that clarified microbial causation and vector transmission.

Etiology and Pathogenesis

Causation is attributed to Yersinia pestis, a gram-negative coccobacillus first isolated by Alexandre Yersin and Kitasato Shibasaburō during the 1894 Hong Kong plague outbreaks involving shipping routes linking Canton, Shanghai, and Nagasaki. Transmission cycles involve commensal and wild Rattus norvegicus, Rattus rattus, and sylvatic reservoirs in Prairie dog populations in North America disseminated by flea vectors such as Xenopsylla cheopis. Pathogenesis includes bacterial invasion of lymph nodes producing bubo formation, endotoxin-mediated systemic inflammation with cytokine cascades studied in models by researchers at institutions like Institut Pasteur and Rockefeller University. Experimental work by Paul-Louis Simond established flea blockage and regurgitation as mechanisms, while molecular studies have implicated plasmids pMT1, pCD1, and virulence factors documented in publications from Harvard Medical School and Johns Hopkins University.

Epidemiology

Contemporary endemic foci persist in parts of Madagascar, Democratic Republic of the Congo, Peru, Bolivia, Mongolia, and the western United States with surveillance networks coordinated by World Health Organization and national ministries of health like Ministry of Health (Madagascar). Human incidence correlates with rodent epizootics, climatic variability studied in El Niño–Southern Oscillation research, land-use change investigated by teams at University of California, Berkeley and Stanford University, and socioeconomic determinants examined by United Nations agencies. International travel and trade historically spread plague along routes including the Silk Road, Indian Ocean trade, and 19th-century shipping lanes linking ports such as Alexandria, Bombay, Hong Kong, and San Francisco. Data collection and modeling efforts have been advanced by groups at Imperial College London and Centers for Disease Control and Prevention.

Clinical Presentation and Diagnosis

Patients typically present with abrupt fever, toxemia, and tender buboes in regional lymph node basins such as cervical, axillary, or inguinal chains documented in case series from Madagascar hospitals and San Francisco General Hospital. Complications include secondary pneumonic plague facilitating person-to-person transmission in outbreaks described in Manchuria and Los Angeles County; meningitis and septicemia can culminate in Disseminated intravascular coagulation and multiorgan failure reported in cohorts managed at Mayo Clinic and Mount Sinai Hospital. Diagnosis relies on culture of clinical specimens, polymerase chain reaction assays developed at Centers for Disease Control and Prevention and Institut Pasteur, and rapid antigen tests validated in field studies by Médecins Sans Frontières and national laboratories.

Treatment and Prevention

Effective antibiotic regimens include aminoglycosides such as streptomycin and gentamicin; tetracyclines like doxycycline and fluoroquinolones such as ciprofloxacin are alternatives recommended in guidelines from World Health Organization and Centers for Disease Control and Prevention. Supportive care in intensive care units at tertiary centers like Johns Hopkins Hospital addresses shock and respiratory failure; prophylactic antibiotics are used for close contacts as practiced during outbreaks in Madagascar and Uganda. Preventive strategies emphasize vector control, rodent management, personal protective equipment used by Médecins Sans Frontières and Red Cross teams, and candidate vaccines investigated by researchers at GlaxoSmithKline, Pasteur Institute, and National Institutes of Health.

Public Health Response and Surveillance

Response frameworks deploy case finding, contact tracing, laboratory confirmation at reference centers such as Centers for Disease Control and Prevention and Institut Pasteur, and risk communication led by World Health Organization and national ministries exemplified by past emergency responses in Madagascar and Democratic Republic of the Congo. International health regulations coordinated by World Health Organization guide notification, travel advisories issued by agencies like International Air Transport Association, and capacity building supported by USAID, European Centre for Disease Prevention and Control, and philanthropic organizations including Bill & Melinda Gates Foundation. Ongoing surveillance integrates ecological monitoring by teams from Smithsonian Institution and genomic epidemiology employing sequencing platforms from Wellcome Sanger Institute and Broad Institute.

Category:Plague